Toggle Offcanvas
...
 
Dimenhydrinate Tenders

Dimenhydrinate Tenders

View Dimenhydrinate tenders, RFPs and contracts. Bid on readily available Dimenhydrinate tenders with the best and most comprehensive tendering platform, since 2002.
Dimenhydrinate is an antihistamine used to prevent and treat motion sickness, nausea, and dizziness. It works by blocking signals in the brain that trigger vomiting and balance issues.

Bidding for Dimenhydrinate tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Dimenhydrinate.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Dimenhydrinate market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Dimenhydrinate tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

11 Live Notices for Dimenhydrinate Tenders

Showing 1 to 11

Open House Pharmaceutical Department Cinarizi And Dimenhydrinate, Atc N07Ca22
country Germany
posting date16 Apr 2025
deadline05 Apr 2027
Pharmaceutical Discount Contracts From June 1St, 2025 On Various Active Ingredients As Part Of An Open House Procedure
country Germany
posting date15 Apr 2025
deadline01 Apr 2027
Medicines With The Combination Of Active Ingredients Cinnaricine And Dimen Hydrinate (Atc: N07Ca22)
country Germany
posting date10 Apr 2025
deadline31 Mar 2027
Medicines With The Combination Of Active Ingredients Cinnaricine And Dimen Hydrinate (Atc: N07Ca22)
country Germany
posting date10 Apr 2025
deadline31 Mar 2027
Completion Of A Non -Exclusive Discount Contract According To Section 130A (8) Sgb V On Pharmaceuticals With The Active Ingredient Combination Of Cinnaricine And Dimensory (N07Ca22).
country Germany
posting date04 Apr 2025
deadline27 Mar 2027
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Cinnaricine/Dimenhydrinate (Atc Code According To Who: N07Ca52; Official Atc: N07Ca22)
country Germany
posting date25 Mar 2025
deadline30 Apr 2027
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Cinnaricine/Dimenhydrinate (Atc Code According To Who: N07Ca52; Official Atc: N07Ca22)
country Germany
posting date25 Mar 2025
deadline30 Apr 2027
Shbsh Even 2
country Uzbekistan
posting date19 May 2025
deadline18 May 2026
Polyclinic Even 2
country Uzbekistan
posting date05 May 2025
deadline04 May 2026
Tab Chlorthalidone 12 Point 5 Mg,Tab Cinnarazine 20Mg Plus Dimenhydrinate 40Mg,Pre Pro Biotic Cap O Quantity: 320150
country India
posting date20 Jun 2025
deadline11 Jul 2025
Mft_Medical_(Ph No.:39017) Cinnarizine + Dimenhydrinate Tab
country India
posting date18 Jun 2025
deadline10 Jul 2025

Share Share this page